Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €0.0050 EUR
Change Today 0.00 / 0.00%
Volume 0.0
STU On Other Exchanges
As of 4:00 PM 07/30/15 All times are local (Market data is delayed by at least 15 minutes).

sembiosys genetics inc (STU) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SEMBIOSYS GENETICS INC (STU)

Related News

No related news articles were found.

sembiosys genetics inc (STU) Related Businessweek News

No Related Businessweek News Found

sembiosys genetics inc (STU) Details

SemBioSys Genetics Inc., a development stage biotechnology company, engages in the development, manufacture, and commercialization of healthy living, animal health, and pharmaceutical products. The company develops products through its patented plant seed based oilbody genetic expression and manufacturing technology platforms. Its products include Biosimilar Insulin, which is derived from genetically engineered safflower for the treatment of diabetes; and apolipoprotein AIMilano, a human protein to reduce, stabilize, and reverse the formation of vascular atherosclerotic plaque for the prevention and treatment of cardiovascular disease. The company’s products also comprise gamma linolenic acid, an omega-6 fatty acid used in topical, functional food, and nutrition products; Chymosin, a food enzyme used in the manufacture of food products; and specialty ingredients. In addition, it provides contract research services. SemBioSys Genetics Inc. is headquartered in Calgary, Canada.

21 Employees
Last Reported Date: 03/30/12

sembiosys genetics inc (STU) Top Compensated Officers

Chief Financial Officer
Total Annual Compensation: --
Vice President of Operations and Legal Affair...
Total Annual Compensation: --
President of Us and International Operations
Total Annual Compensation: --
Director of Business Development
Total Annual Compensation: --
Interim Controller
Total Annual Compensation: --
Compensation as of Fiscal Year 2015.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
STU:GR €0.01 EUR 0.00

STU Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for STU.
View Industry Companies

Industry Analysis


Industry Average

Valuation STU Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.4x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SEMBIOSYS GENETICS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at